We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Chemical ‘Sponges’ Soak up Toxic Chemotherapy Drugs

By HospiMedica International staff writers
Posted on 20 Jun 2016
A new device soaks up chemotherapy drugs before they can circulate widely throughout the body, enabling higher doses and limiting off-target effects in other organs.

The ChemoFilter system, developed by researchers at the Lawrence Berkeley National Laboratory (LBL, Berkeley, CA, USA) and the University of California (UC, Berkeley, USA), is comprised of a nickel-titanium metal frame (in a collapsible flower-petal array), attached to a thin polymer membrane that can be expanded out into a blood vessel from within a catheter. More...
The polymer membrane contains polyethylene for strength and flexibility, as well as sulfonic acid, which has a negative electric charge that attracts and binds drug molecules.

Certain types of chemotherapy drugs, such as doxorubicin, which is used to treat liver cancer, have a positive charge, so the polymer membrane material can bind the drugs via their electric charge, while allowing other types of molecules to flow through. In a preclinical study, a ChemoFilter device was inserted into a pig and was found to reduce the peak concentration of the doxorubicin by about 85%. According to the researchers, the drug-capture system could also potentially be applied to antibiotic treatments.

“Doxorubicin has been around for decades. It is very well understood, and it is also very toxic. If you get exposed to too much, when it goes through the heart you can go into heart failure,” said interventional neuroradiologist Steven Hetts, MD, of the University of California, San Francisco (UCSF; USA), inventor of the ChemoFilter, who specializes in treating eye tumors. “You can get very high concentrations of that chemotherapy in the eye and relatively low concentrations in the rest of the body, but some will wash through the eye and into the veins in the head, so you can have side effects from that.”

“We used to use this material for transporting protons in a fuel cell. I was really excited when I found out this could be used for chemotherapy - this was branching out in a totally different direction,” said lead researcher X. Chelsea Chen, PhD, a postdoctoral researcher at LBL. “We are actively searching for new materials and mechanisms for the polymer membranes. Researchers are exploring the use of 3D-printed materials, for example, that can be coated with charged particles to attract and bind drug molecules.”

Related Links:
Lawrence Berkeley National Laboratory
University of California
University of California, San Francisco

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.